humans |
213 |
covid-19 |
156 |
female |
132 |
male |
132 |
animals |
126 |
adult |
124 |
sars-cov-2 |
117 |
middle aged |
103 |
coronavirus |
87 |
hong kong - epidemiology |
79 |
aged |
76 |
influenza |
73 |
phylogeny |
71 |
molecular sequence data |
68 |
child |
62 |
hong kong |
62 |
mice |
61 |
adolescent |
59 |
child, preschool |
59 |
base sequence |
54 |
infant |
54 |
polymerase chain reaction |
54 |
disease outbreaks |
52 |
sequence analysis, dna |
50 |
genotype |
49 |
amino acid sequence |
48 |
cell line |
46 |
children |
46 |
reverse transcriptase polymerase chain reaction |
46 |
viral load |
46 |
molecular epidemiology |
44 |
time factors |
44 |
antiviral |
43 |
sars-cov |
43 |
china - epidemiology |
42 |
epidemiology |
41 |
influenza virus |
40 |
medical sciences |
40 |
risk factors |
40 |
china |
39 |
treatment outcome |
39 |
cohort studies |
38 |
influenza a virus |
38 |
vaccine |
38 |
cell line, tumor |
37 |
h5n1 |
37 |
prospective studies |
37 |
retrospective studies |
37 |
transmission |
37 |
diagnosis |
36 |
incidence |
36 |
infection |
36 |
interferon |
36 |
sars |
36 |
sensitivity and specificity |
36 |
severe acute respiratory syndrome |
36 |
virulence |
36 |
virus replication |
36 |
antibodies, viral - blood |
35 |
pandemic |
35 |
rna, viral - genetics |
35 |
aged, 80 and over |
34 |
mutation |
34 |
genome, viral |
33 |
pathogenesis |
33 |
prevalence |
33 |
bronchiectasis |
32 |
microbial sensitivity tests |
32 |
nasopharyngeal carcinoma |
32 |
sars coronavirus |
32 |
cells, cultured |
31 |
sequence homology, amino acid |
31 |
treatment |
31 |
anti-bacterial agents - pharmacology |
29 |
seasons |
29 |
severity of illness index |
29 |
vaccination |
29 |
case-control studies |
28 |
evolution, molecular |
28 |
flavivirus |
28 |
genetic variation |
28 |
phenotype |
28 |
young adult |
28 |
chemicals and cas registry numbers |
27 |
enzyme-linked immunosorbent assay |
27 |
follow-up studies |
27 |
human |
27 |
immune response |
27 |
apoptosis |
26 |
blotting, western |
26 |
enterovirus |
26 |
hemagglutinin |
26 |
immunocompromised host |
26 |
mers-cov |
26 |
sequence alignment |
26 |
ace2 |
25 |
birds - virology |
25 |
evolution |
25 |
fatal outcome |
25 |
inhibitor |
25 |
lipidomics |
25 |
metabolomics |
25 |
mice, inbred balb c |
25 |
models, molecular |
25 |
neutralization tests |
25 |
risk assessment |
25 |
serotyping |
25 |
amino acid substitution |
24 |
antiviral agents - therapeutic use |
24 |
chiroptera - virology |
24 |
gene expression |
24 |
genetic predisposition to disease |
24 |
h7n9 |
24 |
influenza, human - epidemiology - virology |
24 |
pandemics |
24 |
serology |
24 |
zika |
24 |
antigens, viral - analysis |
23 |
burkholderia pseudomallei |
23 |
cattle |
23 |
epstein-barr virus |
23 |
flow cytometry |
23 |
genome |
23 |
hospitalization |
23 |
influenza a virus, h1n1 subtype - immunology |
23 |
molecular sequence numbers |
23 |
swine - virology |
23 |
up-regulation |
23 |
age factors |
22 |
bone marrow transplantation |
22 |
bone marrow transplantation - adverse effects |
22 |
chinese |
22 |
dogs |
22 |
feces - virology |
22 |
hemagglutination inhibition tests |
22 |
mouse |
22 |
neutralizing antibody |
22 |
omicron |
22 |
polymerase chain reaction - methods |
22 |
survival rate |
22 |
swine |
22 |
temperature |
22 |
viral replication |
22 |
antibody |
21 |
bat |
21 |
cercopithecus aethiops |
21 |
cluster analysis |
21 |
cytokine |
21 |
prognosis |
21 |
transcription, genetic |
21 |
animal |
20 |
avian influenza |
20 |
bacterial typing techniques |
20 |
biomarkers |
20 |
birds |
20 |
cloning, molecular |
20 |
cytokines |
20 |
novel |
20 |
polymorphism, genetic |
20 |
protein structure, tertiary |
20 |
sars virus - immunology |
20 |
species specificity |
20 |
viral proteins - genetics |
20 |
asthma |
19 |
biomarker |
19 |
cricetinae |
19 |
cross protection |
19 |
disease outbreaks - statistics & numerical data |
19 |
disease reservoirs - virology |
19 |
dna primers |
19 |
dna, viral - genetics |
19 |
gene silencing |
19 |
genes, viral |
19 |
immunity |
19 |
influenza, human - virology |
19 |
mrsa |
19 |
nasopharynx - virology |
19 |
promoter regions, genetic |
19 |
reproducibility of results |
19 |
respiratory system - virology |
19 |
signal transduction |
19 |
spike protein |
19 |
susceptibility |
19 |
virus replication - drug effects |
19 |
administration, oral |
18 |
animal experiment |
18 |
gene expression regulation |
18 |
hela cells |
18 |
influenza a virus, h1n1 subtype - genetics |
18 |
influenza a virus, h1n1 subtype - genetics - pathogenicity |
18 |
influenza in birds - virology |
18 |
influenza vaccine |
18 |
lung - radiography |
18 |
melioidosis |
18 |
microscopy, electron |
18 |
mortality |
18 |
mucosal immunity |
18 |
mutation - genetics |
18 |
neutralizing antibodies |
18 |
pathogenicity |
18 |
pcr |
18 |
pneumonia |
18 |
population surveillance |
18 |
poultry - virology |
18 |
predictive value of tests |
18 |
receptor binding domain |
18 |
seroepidemiologic studies |
18 |
t-lymphocytes, cytotoxic - immunology |
18 |
transfection |
18 |
age |
17 |
animal model |
17 |
antibodies, monoclonal - immunology |
17 |
antibody titer |
17 |
antimicrobial resistance |
17 |
coronavirus - classification - genetics - isolation & purification |
17 |
diagnosis, differential |
17 |
epidemics |
17 |
h1n1 |
17 |
influenza, human - diagnosis - virology |
17 |
kinetics |
17 |
outbreak |
17 |
public health |
17 |
rat |
17 |
rats |
17 |
recombination, genetic |
17 |
respiratory tract infections |
17 |
rhinovirus |
17 |
rna, small interfering - genetics |
17 |
severe acute respiratory syndrome - drug therapy |
17 |
virus attachment |
17 |
acute disease |
16 |
angiogenesis |
16 |
avian |
16 |
bacterial proteins - genetics |
16 |
convalescence |
16 |
coronavirus - genetics - isolation & purification |
16 |
coronavirus disease 2019 |
16 |
disease progression |
16 |
drug resistance, bacterial |
16 |
electrophoresis, gel, pulsed-field |
16 |
escherichia coli |
16 |
fatty acid |
16 |
genomics |
16 |
hepatitis b virus |
16 |
hiv |
16 |
hiv-1 |
16 |
human immunodeficiency virus |
16 |
immune activation |
16 |
immunohistochemistry |
16 |
inactivated vaccine |
16 |
influenza a virus, h1n1 subtype - genetics - immunology |
16 |
influenza a virus, h5n1 subtype - genetics - immunology |
16 |
influenza in birds - epidemiology - virology |
16 |
microbiology |
16 |
oseltamivir |
16 |
penicillium marneffei |
16 |
protein binding |
16 |
reverse transcriptase polymerase chain reaction - methods |
16 |
rnai |
16 |
saliva |
16 |
swine diseases - virology |
16 |
uplc-esi-q-tof-ms |
16 |
vaccination - methods |
16 |
virus |
16 |
adaptation |
15 |
adenovirus |
15 |
alanine transaminase - blood |
15 |
amino acid motifs |
15 |
animal tissue |
15 |
bacteremia |
15 |
betacoronavirus |
15 |
binding sites |
15 |
coronavirus - immunology |
15 |
cross reactions |
15 |
dendritic cells |
15 |
disease outbreaks - prevention & control |
15 |
dna, bacterial - chemistry - genetics |
15 |
drug resistance |
15 |
drug therapy, combination |
15 |
glycosylation |
15 |
graft rejection |
15 |
homozygote |
15 |
immunity, innate |
15 |
influenza a |
15 |
influenza a virus, h1n1 subtype - immunology - pathogenicity |
15 |
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
15 |
influenza a virus, h5n1 subtype - immunology |
15 |
live attenuated vaccine |
15 |
mask |
15 |
metagenomics |
15 |
mycobacterium tuberculosis |
15 |
nucleoprotein |
15 |
pb2 |
15 |
plasmids |
15 |
poultry |
15 |
pregnancy |
15 |
replication |
15 |
sars virus - genetics - isolation & purification |
15 |
sars virus - isolation & purification |
15 |
virus evolution |
15 |
virus shedding |
15 |
2009 h1n1 influenza |
14 |
animal cell |
14 |
anosmia |
14 |
anti-bacterial agents - therapeutic use |
14 |
antimicrobial |
14 |
asymptomatic |
14 |
biodiversity |
14 |
blood donors |
14 |
cell division |
14 |
coinfection |
14 |
coronavirus infection |
14 |
diagnostics |
14 |
disease models, animal |
14 |
fishes - microbiology |
14 |
immunosuppressive agents - therapeutic use |
14 |
influenza a virus, h1n1 subtype - immunology - isolation and purification - pathogenicity |
14 |
influenza a virus, h1n1 subtype - isolation and purification |
14 |
influenza a virus, h5n1 subtype |
14 |
influenza, human - immunology - pathology - virology |
14 |
injections, intramuscular |
14 |
intestine |
14 |
lymphocyte activation |
14 |
macrophages |
14 |
membrane glycoproteins - metabolism |
14 |
models, biological |
14 |
nf-kappa b - metabolism |
14 |
olfactory dysfunction |
14 |
plasma |
14 |
protease |
14 |
protein conformation |
14 |
real-time pcr |
14 |
rna interference |
14 |
sars virus - metabolism - pathogenicity |
14 |
spike |
14 |
staphylococcus aureus |
14 |
tuberculosis |
14 |
tumor cells, cultured |
14 |
virus replication - physiology |
14 |
amino acid substitution - genetics |
13 |
antibiotic prophylaxis |
13 |
antibodies |
13 |
antibodies, neutralizing - blood |
13 |
antiviral agents - pharmacology |
13 |
bird diseases - epidemiology - virology |
13 |
bismuth |
13 |
bunyavirales |
13 |
carcinoma, hepatocellular - genetics - metabolism |
13 |
carrier state - microbiology |
13 |
cats |
13 |
cell differentiation |
13 |
chicken |
13 |
clarithromycin |
13 |
conjunctivitis |
13 |
corticosteroid |
13 |
covid‐19 |
13 |
cytokine and chemokine response |
13 |
cytokines - metabolism |
13 |
d222g |
13 |
diarrhea - microbiology |
13 |
disease reservoirs |
13 |
dna vaccine |
13 |
dna, bacterial - genetics |
13 |
food microbiology |
13 |
immunization |
13 |
immunoglobulin g - blood |
13 |
infection control |
13 |
influenza, human - immunology |
13 |
influenza, human - mortality |
13 |
intradermal |
13 |
laribacter hongkongensis |
13 |
liver neoplasms - genetics - metabolism |
13 |
mers |
13 |
mice, nude |
13 |
nucleocapsid proteins - genetics - immunology |
13 |
point mutation |
13 |
polymorphism, single nucleotide |
13 |
receptors, cell surface - metabolism |
13 |
rhizopus microsporus |
13 |
ribavirin |
13 |
s. aureus |
13 |
sace2 |
13 |
sars virus - drug effects |
13 |
sars-cov-2 variants |
13 |
sequence homology, nucleic acid |
13 |
severe acute respiratory syndrome - diagnosis - virology |
13 |
species index: fungi |
13 |
spike glycoprotein |
13 |
staphylococcal infections - microbiology |
13 |
t-lymphocytes - immunology |
13 |
acute hepatitis |
12 |
adolescents |
12 |
airborne |
12 |
anti-bacterial agents |
12 |
antibiotic resistance |
12 |
astroviridae - classification - genetics - isolation and purification |
12 |
astroviridae infections - epidemiology - veterinary - virology |
12 |
bacteremia - microbiology |
12 |
bacteriological techniques |
12 |
case report |
12 |
chronic obstructive lung disease |
12 |
combination therapy |
12 |
controlled study |
12 |
copd |
12 |
dna primers - genetics |
12 |
enterobacteriaceae |
12 |
false positive |
12 |
feces - microbiology |
12 |
genetic vectors |
12 |
hepatitis e |
12 |
immunotherapy |
12 |
infant, newborn |
12 |
infectivity |
12 |
influenza a virus, h5n1 subtype - classification - genetics |
12 |
influenza a virus, h5n1 subtype - immunology - pathogenicity |
12 |
influenza, human - epidemiology - immunology - virology |
12 |
influenza, human - epidemiology - pathology - virology |
12 |
influenza, human - epidemiology - transmission - virology |
12 |
kawasaki disease |
12 |
lopinavir |
12 |
methicillin resistance |
12 |
methicillin-resistant staphylococcus aureus |
12 |
molecular diagnostic techniques - methods |
12 |
nose - virology |
12 |
open reading frames |
12 |
organ size |
12 |
polymorphism, restriction fragment length |
12 |
proteomics |
12 |
pseudomonas aeruginosa |
12 |
randomized controlled trial |
12 |
rna, messenger - genetics - metabolism |
12 |
rna, ribosomal, 16s - genetics |
12 |
rna, viral - metabolism |
12 |
rt-lamp |
12 |
sars-cov-2 rbd igg |
12 |
sftsv |
12 |
t cell response |
12 |
tomography, x-ray computed |
12 |
urine - virology |
12 |
viral persistence |
12 |
virus cultivation |
12 |
2′-o-methyltransferase |
11 |
acute respiratory illness |
11 |
algorithms |
11 |
animal models |
11 |
animals, wild - virology |
11 |
anthranilic acid |
11 |
antibodies, viral - biosynthesis |
11 |
antifungal agents - therapeutic use |
11 |
antiviral agents - chemical synthesis - chemistry - pharmacology |
11 |
asian continental ancestry group |
11 |
ba.5.2 |
11 |
bacteriological techniques - methods |
11 |
bone marrow transplantation - immunology |
11 |
broad spectrum |
11 |
carboxypeptidases - antagonists & inhibitors - metabolism |
11 |
cell adhesion molecules - genetics - metabolism |
11 |
cell proliferation |
11 |
cell transformation, neoplastic |
11 |
chemokine |
11 |
cho cells - virology |
11 |
contamination |
11 |
cricetulus |
11 |
cross-reactive |
11 |
diagnostic |
11 |
diarrhea - epidemiology - microbiology |
11 |
dna, bacterial - analysis |
11 |
dna, viral - blood |
11 |
dose-response relationship, drug |
11 |
down-regulation |
11 |
dromedary camels |
11 |
drug resistance, bacterial - genetics |
11 |
drug synergism |
11 |
ducks - virology |
11 |
early diagnosis |
11 |
endoplasmic reticulum |
11 |
entry |
11 |
enzyme-linked immunosorbent assay - methods |
11 |
feces analysis |
11 |
fluorescent antibody technique, indirect |
11 |
gene deletion |
11 |
genes, bacterial |
11 |
genes, rrna |
11 |
glycoprotein |
11 |
graft survival |
11 |
hamster |
11 |
hand |
11 |
hcov-229e |
11 |
influenza a virus, h1n1 subtype - genetics - immunology - isolation and purification |
11 |
influenza a virus, h5n1 subtype - pathogenicity |
11 |
influenza in birds - epidemiology - transmission - virology |
11 |
influenza vaccines - immunology |
11 |
influenza, human - epidemiology |
11 |
influenza, human - immunology - virology |
11 |
intestine, small - physiology |
11 |
isolation |
11 |
kidney transplantation |
11 |
lectins, c-type - genetics - metabolism |
11 |
lung - physiology - virology |
11 |
membrane glycoproteins - genetics |
11 |
murine |
11 |
n501y |
11 |
neutralization |
11 |
next-generation sequencing |
11 |
nsp16 |
11 |
nucleic acid conformation |
11 |
open reading frames - genetics |
11 |
phage display |
11 |
pharynx - virology |
11 |
plasmids - genetics |
11 |
proteasome endopeptidase complex - metabolism |
11 |
receptors, cell surface - genetics - metabolism |
11 |
respiratory tract infection |
11 |
rna, messenger - analysis |
11 |
sars virus - drug effects - growth & development - metabolism - physiology |
11 |
sars virus - genetics |
11 |
severe acute respiratory syndrome - epidemiology - genetics |
11 |
severe acute respiratory syndrome - epidemiology - immunology - virology |
11 |
species index: animalia |
11 |
statistics, nonparametric |
11 |
sterilizing immunity |
11 |
stool |
11 |
structure-activity relationship |
11 |
t-cell response |
11 |
talaromyces marneffei |
11 |
tandem repeat sequences |
11 |
tsukamurella |
11 |
vero cells - virology |
11 |
viral envelope proteins - genetics - immunology |
11 |
viral matrix proteins - antagonists & inhibitors - metabolism |
11 |
zoonosis |
11 |
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
adiponectin |
10 |
adoptive transfer |
10 |
aids |
10 |
airborne infection |
10 |
alleles |
10 |
animals, domestic - virology |
10 |
antibody specificity |
10 |
antigen-presentation |
10 |
asia |
10 |
autoantibodies - blood |
10 |
autoantibody |
10 |
autophagy |
10 |
bacteria |
10 |
bats |
10 |
bayes theorem |
10 |
bird diseases - virology |
10 |
blood culture |
10 |
body weight |
10 |
canada - epidemiology |
10 |
cancer |
10 |
cell separation |
10 |
cell tropism |
10 |
chick embryo |
10 |
circular dichroism |
10 |
combined modality therapy |
10 |
community-acquired infections - epidemiology - microbiology |
10 |
conserved sequence |
10 |
coronavirus - classification - genetics |
10 |
coronavirus - immunology - pathogenicity - physiology |
10 |
coronavirus infections - immunology - virology |
10 |
covid19 |
10 |
culture media |
10 |
cyclooxygenase 2 - biosynthesis - genetics |
10 |
cyclooxygenase 2 inhibitors |
10 |
cytokines - biosynthesis - immunology |
10 |
cytokines - blood |
10 |
cytomegalovirus |
10 |
cytopathogenic effect, viral |
10 |
d225g |
10 |
damplicon |
10 |
dead-box rna helicases - genetics - immunology - metabolism |
10 |
disease outbreaks - history |
10 |
disease severity |
10 |
drug interactions |
10 |
drug therapy, combination - therapeutic use |
10 |
ecosystem |
10 |
epithelial cells - immunology - metabolism |
10 |
erythromycin - pharmacology |
10 |
gene |
10 |
genetics |
10 |
genome, bacterial |
10 |
hemagglutinin glycoproteins, influenza virus - genetics |
10 |
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
hepatitis |
10 |
history, 20th century |
10 |
history, 21st century |
10 |
hospitalization - statistics and numerical data |
10 |
human adenovirus |
10 |
human neutralizing antibody |
10 |
identification |
10 |
immunoassay - methods |
10 |
immunogenicity |
10 |
infectious disease |
10 |
influenza a virus - isolation & purification |
10 |
influenza a virus, h1n1 subtype - physiology |
10 |
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
influenza a virus, h5n1 subtype - metabolism |
10 |
influenza a virus, h5n1 subtype - physiology |
10 |
influenza h1n1 |
10 |
influenza in birds - enzymology - immunology - virology |
10 |
influenza, human - enzymology - virology |
10 |
influenza, human - immunology - metabolism - virology |
10 |
influenza, human - metabolism - transmission |
10 |
interferon regulatory factor-3 - metabolism |
10 |
janus kinases - immunology |
10 |
kidney transplantation - adverse effects |
10 |
linker-immunodominant site |
10 |
liver function tests |
10 |
logistic models |
10 |
lung injury |
10 |
macaca mulatta |
10 |
macrophage |
10 |
macrophages - immunology |
10 |
macrophages - immunology - metabolism |
10 |
membrane glycoproteins - immunology |
10 |
mice, inbred c57bl |
10 |
middle east |
10 |
models, theoretical |
10 |
molecular structure |
10 |
mouth - microbiology |
10 |
mrna |
10 |
ms |
10 |
mycobacterium |
10 |
nasal turbinate |
10 |
neoplasm transplantation |
10 |
neuraminidase - genetics |
10 |
npc |
10 |
orthomyxoviridae infections - epidemiology - transmission - veterinary - virology |
10 |
p38 mitogen-activated protein kinases - metabolism |
10 |
paracrine communication - immunology |
10 |
patient admission - statistics and numerical data |
10 |
penicillium - genetics |
10 |
peptide |
10 |
picornaviridae - chemistry - classification - genetics - isolation and purification |
10 |
pneumonia, viral - immunology - virology |
10 |
pulmonary alveoli - immunology - metabolism |
10 |
rats, sprague-dawley |
10 |
receptor, interferon alpha-beta - immunology |
10 |
recombination |
10 |
recurrence |
10 |
reverse genetics |
10 |
rna, viral - genetics - isolation & purification |
10 |
rt-pcr |
10 |
sars virus - genetics - immunology |
10 |
sars virus - isolation and purification |
10 |
sars virus - physiology |
10 |
seasonality |
10 |
sequence deletion |
10 |
sequence homology |
10 |
sequencing |
10 |
seroprevalence |
10 |
severe acute respiratory syndrome - diagnosis |
10 |
severe acute respiratory syndrome - epidemiology - transmission - virology |
10 |
severe acute respiratory syndrome - prevention & control |
10 |
severe acute respiratory syndrome - virology |
10 |
sialic acid |
10 |
specific |
10 |
steroid |
10 |
swine-origin |
10 |
toll-like receptor 3 - metabolism |
10 |
transplantation, heterologous |
10 |
upper respiratory tract |
10 |
vaccines, dna - administration & dosage - immunology |
10 |
vietnam - epidemiology |
10 |
viral proteins - chemistry - genetics |
10 |
virology |
10 |
zika virus |
10 |
zoonoses |
10 |
5' untranslated regions |
9 |
adenosine synthase a |
9 |
adjuvant |
9 |
age distribution |
9 |
aged mice |
9 |
airway organoid |
9 |
antibiotic sensitivity |
9 |
antibodies, viral - blood - immunology |
9 |
antibody detection |
9 |
antibody formation |
9 |
antibody-dependent cell-mediated cytotoxicity |
9 |
antigenic variation |
9 |
antigens, cd - metabolism |
9 |
antitubercular agents - therapeutic use |
9 |
antiviral agents - administration and dosage - therapeutic use |
9 |
asia, southeastern |
9 |
asymptomatic infection |
9 |
autoantibodies |
9 |
avian influenza virus |
9 |
bacteraemia |
9 |
bacteremia - epidemiology - microbiology |
9 |
bagg albino mouse |
9 |
bioaerosols |
9 |
biological markers - blood |
9 |
bocavirus - classification - genetics - isolation and purification |
9 |
celecoxib |
9 |
cell culture |
9 |
cell surface |
9 |
chiroptera - classification - virology |
9 |
chromatin accessibility |
9 |
circrna |
9 |
clinical outcome |
9 |
community-acquired infections - microbiology |
9 |
comorbidity |
9 |
consensus sequence |
9 |
convalescent |
9 |
coronavac |
9 |
coronavirus infections - genetics |
9 |
coronavirus infections - veterinary - virology |
9 |
cross infection - epidemiology - immunology |
9 |
cross-protection |
9 |
cytokines - biosynthesis |
9 |
deleted in liver cancer 2 |
9 |
diagnostic errors |
9 |
diversity |
9 |
dna fingerprinting |
9 |
dna, viral - chemistry - genetics |
9 |
dogs - virology |
9 |
dromedary camel |
9 |
drug resistance, viral |
9 |
drug resistance, viral - genetics |
9 |
emerging |
9 |
epidemic |
9 |
epithelial cells - virology |
9 |
epstein–barr virus |
9 |
etiology |
9 |
ex vivo |
9 |
ex vivo human lung tissues |
9 |
fc-rbd |
9 |
fluorescent antibody technique |
9 |
gene therapy |
9 |
genome mutation |
9 |
glycoproteins - metabolism |
9 |
gram-negative bacterial infections - diagnosis - microbiology |
9 |
h1n1 influenza virus |
9 |
hku1 |
9 |
hospitals, university |
9 |
host-virus interaction |
9 |
hot temperature |
9 |
human coronavirus hku1 |
9 |
human primary nasal epithelial cells |
9 |
human respiratory syncytial virus |
9 |
illumina sequencing |
9 |
immune protection |
9 |
immunization, secondary |
9 |
immunoglobulin g - analysis - immunology |
9 |
immunology |
9 |
influenza a virus - pathogenicity |
9 |
influenza a virus - physiology |
9 |
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification - physiology |
9 |
influenza a virus, h1n1 subtype - genetics - isolation and purification - physiology |
9 |
influenza b |
9 |
influenza vaccines - administration and dosage |
9 |
influenza, human - epidemiology - prevention & control - transmission - virology |
9 |
influenza-virus |
9 |
injections, intravenous |
9 |
internalization |
9 |
kidney - cytology |
9 |
lethal mouse model |
9 |
liver diseases - epidemiology |
9 |
liver transplantation - statistics & numerical data |
9 |
lung damage |
9 |
lung pathology |
9 |
lupus erythematosus, systemic - complications |
9 |
mamastrovirus - classification - genetics - isolation & purification |
9 |
masks |
9 |
mass spectrometry |
9 |
membrane glycoproteins - analysis |
9 |
membrane glycoproteins - chemistry - genetics |
9 |
mesalazine |
9 |
mice, scid |
9 |
middle east respiratory syndrome |
9 |
middle east respiratory syndrome coronavirus |
9 |
mitochondria |
9 |
model |
9 |
models, chemical |
9 |
models, genetic |
9 |
molecular diagnosis |
9 |
multivariate analysis |
9 |
myocardial infarction - mortality - prevention and control |
9 |
nmr |
9 |
novel species |
9 |
nucleocapsid proteins - genetics |
9 |
nucleolin |
9 |
omicron variant |
9 |
operating rooms |
9 |
orchitis |
9 |
orthomyxoviridae infections - immunology - mortality - physiopathology - virology |
9 |
parvoviridae infections - veterinary - virology |
9 |
peptides - metabolism |
9 |
peritonitis |
9 |
phosphatidic acid phosphatases |
9 |
phylogenetic tree |
9 |
plasmid |
9 |
pneumococcal vaccines - administration and dosage |
9 |
pneumonia, viral - epidemiology - immunology - virology |
9 |
pneumonia, viral - virology |
9 |
point-of-care testing |
9 |
post-ba.2/5 subvariants |
9 |
promoter regions, genetic - genetics |
9 |
proximal differentiation |
9 |
reagent kits, diagnostic |
9 |
recombinant proteins - analysis - immunology |
9 |
renal transplant |
9 |
respiratory |
9 |
respiratory virus |
9 |
resting-state fmri |
9 |
ribosomes - genetics - metabolism |
9 |
rig-i |
9 |
rna, viral - analysis |
9 |
rna, viral - analysis - genetics |
9 |
sars virus |
9 |
sars virus - metabolism |
9 |
sars-cov-2 variants of concern |
9 |
sars‐cov‐2 |
9 |
screening |
9 |
seroepidemiology |
9 |
severe acute respiratory syndrome - immunology - virology |
9 |
smell impairment |
9 |
smoking |
9 |
streptococcus pneumoniae |
9 |
stroke - mortality - prevention and control |
9 |
swine - blood - virology |
9 |
swine diseases - blood - epidemiology - transmission - virology |
9 |
taxonomy |
9 |
testis |
9 |
th1 cells - immunology |
9 |
tissue donors |
9 |
transplantation, homologous |
9 |
transplantation, homologous - adverse effects |
9 |
tumor microenvironment |
9 |
vaccines, inactivated - administration & dosage - immunology |
9 |
vancomycin resistance |
9 |
vero cells |
9 |
victoria lineage |
9 |
viral envelope proteins - analysis |
9 |
viral envelope proteins - chemistry - genetics |
9 |
viral envelope proteins - metabolism |
9 |
viral matrix proteins - genetics |
9 |
viral proteins - genetics - metabolism |
9 |
virulence factors |
9 |
vitamin a |
9 |
vopba |
9 |
weanling mice |
9 |
whole-genome bisulfite sequencing |
9 |
xbb.1 |
9 |
zanamivir |
9 |
25-hydroxycholesterol |
8 |
3clpro inhibitor |
8 |
a(h1n1)pdm09 |
8 |
a(h3n2) |
8 |
adeno-associated virus |
8 |
aerosolised |
8 |
allosteric-site inhibitor |
8 |
am580 |
8 |
antibiotic susceptibility |
8 |
antibodies, monoclonal - diagnostic use |
8 |
antibodies, viral - genetics - immunology - metabolism |
8 |
antibodies, viral - immunology |
8 |
antibody blood level |
8 |
antibody response |
8 |
antigens, cd - genetics - metabolism |
8 |
antiviral agents |
8 |
antiviral agents - chemical synthesis - pharmacology |
8 |
asia - epidemiology |
8 |
aspergillus |
8 |
aspergillus fumigatus |
8 |
autopsy |
8 |
avian influenza a virus |
8 |
b cell |
8 |
b-cell suppression |
8 |
bacterium |
8 |
biliary atresia - complications - surgery |
8 |
binding sites - genetics |
8 |
bioaerosol |
8 |
biology |
8 |
biopsy |
8 |
biotechnology technology: comprehensive works medical sciences chemistry |
8 |
blotting, southern |
8 |
broad-spectrum antiviral treatment |
8 |
bronchi - immunology - pathology |
8 |
carrier proteins - metabolism |
8 |
case study |
8 |
caspase |
8 |
chemical genetics |
8 |
chemokines |
8 |
chi-square distribution |
8 |
child day care centers |
8 |
chromatography, high pressure liquid |
8 |
cilia |
8 |
clostridium difficile |
8 |
community-acquired infections |
8 |
complications of liver transplantation |
8 |
computational biology - methods |
8 |
conjunctiva |
8 |
coronavirus hku1 |
8 |
coronavirus infections - epidemiology - physiopathology - virology |
8 |
coronaviruses |
8 |
cross-species transmission |
8 |
crystal structure |
8 |
cyclosporine - therapeutic use |
8 |
cytokines - genetics - metabolism |
8 |
cytokines - immunology |
8 |
cytotoxicity, immunologic |
8 |
databases, nucleic acid - statistics & numerical data |
8 |
debridement |
8 |
delns1-ncov-rbd laiv |
8 |
dendritic cells - immunology |
8 |
detection |
8 |
diagnostic test evaluation |
8 |
dialysis |
8 |
dipeptidyl peptidase 4 |
8 |
dog diseases - virology |
8 |
elisa |
8 |
emc |
8 |
epstein-barr virus (ebv) |
8 |
extended-spectrum beta-lactamases |
8 |
family characteristics |
8 |
feasibility studies |
8 |
functional brain network |
8 |
fungi |
8 |
ganglioside gm1 antibody |
8 |
gastroenteritis |
8 |
gastroenteritis - microbiology |
8 |
gastrointestinal diseases - microbiology |
8 |
gene amplification |
8 |
gene expression regulation, bacterial |
8 |
gene expression regulation, viral |
8 |
genes, bacterial - genetics |
8 |
genes, viral - genetics |
8 |
genetic vectors - genetics |
8 |
genome, fungal |
8 |
glycolipids |
8 |
glycoproteins - genetics - metabolism |
8 |
gram-positive bacterial infections - microbiology |
8 |
hcov-emc |
8 |
hepatitis b vaccination |
8 |
high throughput screening |
8 |
hiv infections - genetics - metabolism |
8 |
hospitalized |
8 |
hpai |
8 |
human exhaled breath |
8 |
human rhinovirus |
8 |
hypsugo bat |
8 |
il-8 |
8 |
imiquimod |
8 |
immunization schedule |
8 |
immunocompetence |
8 |
immunosuppression |
8 |
immunosuppressive agents - adverse effects - therapeutic use |
8 |
immunotherapy - methods |
8 |
incidence rates |
8 |
influenza a virus - classification - genetics - pathogenicity |
8 |
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
influenza a virus, h1n1 subtype - isolation & purification - pathogenicity |
8 |
influenza a virus, h1n1 subtype - pathogenicity |
8 |
influenza a virus, h5n1 subtype - genetics - physiology |
8 |
influenza a virus, h5n1 subtype - isolation & purification - pathogenicity |
8 |
influenza b virus |
8 |
influenza vaccines |
8 |
integrative-omics |
8 |
interferon lambda 1 |
8 |
interventions |
8 |
intranasal |
8 |
intraoperative complications - epidemiology |
8 |
ip-10 |
8 |
leukocytes - virology |
8 |
lipid |
8 |
liver diseases - etiology - surgery |
8 |
liver transplantation - adverse effects - statistics & numerical data |
8 |
liver transplantation - contraindications - methods - mortality - statistics & numerical data |
8 |
liver transplantation - methods |
8 |
living donor liver transplant |
8 |
living-related liver transplantation |
8 |
long covid |
8 |
marmosets |
8 |
mass screening |
8 |
maturation |
8 |
membrane glycoproteins - genetics - immunology |
8 |
membrane glycoproteins - genetics - immunology - metabolism |
8 |
mers coronavirus |
8 |
metabolism |
8 |
metabolomic |
8 |
metalloimmunity |
8 |
metalloproteomics |
8 |
methicillin-resistant staphylococcus aureus - isolation and purification |
8 |
meticillin-resistant staphylococcus aureus |
8 |
microbial sensitivity tests - methods |
8 |
mitochondrial dysfunction |
8 |
molecular detection |
8 |
molecular typing |
8 |
monoclonal antibody |
8 |
morbidity |
8 |
multidrug resistance |
8 |
mutation, missense |
8 |
mycosis |
8 |
myocarditis |
8 |
nanopore sequencing |
8 |
naproxen |
8 |
nasopharynx - microbiology |
8 |